Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 12:34 PM
Ignite Modification Date: 2025-12-25 @ 12:11 PM
NCT ID: NCT01986361
Description: None
Frequency Threshold: 0
Time Frame: up to 20 hours post dose
Study: NCT01986361
Study Brief: Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Flurbiprofen 8.75 mg Lozenge A single flurbiprofen lozenge is sucked until fully dissolved. None None 0 101 10 101 View
Placebo Lozenge A single placebo lozenge is sucked until fully dissolved. None None 0 21 1 21 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Abdominal discomfort SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (15.1) View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (15.1) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (15.1) View
Throat irritation SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (15.1) View
Tonsillar hypertrophy SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (15.1) View
Laryngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (15.1) View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (15.1) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (15.1) View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (15.1) View
Pyrexia SYSTEMATIC_ASSESSMENT General disorders MedDRA (15.1) View
Conjunctivitis infective SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (15.1) View